Evidence map›Paper›PMID 22833761›Full record

ReviewDeutsches Arzteblatt international2012

The indications for liver biopsy.

Andrea Tannapfel, Hans-Peter Dienes, Ansgar W Lohse

Open access · greenAbstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Evolution of the liver biopsy and its future.Translational gastroenterology and hepatology · 2021
    Review
  7. Article
  8. Article
  9. Endoscopic ultrasound guided liver biopsy: Recent evidence.World journal of gastrointestinal endoscopy · 2020
    Review
  10. Article
  11. Review
  12. Nanoparticles for the treatment of liver fibrosis.International journal of nanomedicine · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Pathology of Alcoholic Liver Disease.Journal of clinical and translational hepatology · 2014
    Review
  18. Review
  19. Review
  20. In reply.Deutsches Arzteblatt international · 2013
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrea TannapfelInstitute of Pathology, Ruhr-University Bochum, Germany. Andrea.Tannapfel@rub.de
Hans-Peter Dienes
Ansgar W Lohse
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite improvements in serological and radiological techniques, liver biopsy remains the most reliable way to diagnose diffuse hepatic disease and hepatic nodules. The indications for this invasive technique must be weighed against the small, but not negligible, risk of a complication.

methodsThe indications for liver biopsy are summarized on the basis of a selective review of the literature, including the published recommendations and position statements of specialty societies in Germany and abroad. The conclusions are supplemented with an evaluation of the authors' own experience.

resultsThe success of liver biopsy depends not only on the selection of the puncture method and on due attention to the relative and absolute contraindications, but also on the experience of the person carrying out the procedure. For patients with hepatitis of various etiologies, liver biopsy is used not only to establish the cause of the disorder, but also to assess the degree of inflammatory activity (grading) and the extent of fibrosis (staging).

conclusionLiver biopsy enables the reliable diagnosis of hepatic lesions and is an important aid to treatment planning and prognostication.

Indexed as

Biopsy, NeedleDiagnosis, DifferentialHumansLiver DiseasesPrevalenceReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID22833761
PMCPMC3402072
OpenAlexW54952080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.